
Incredible news to see the FDA approval of giredestrant + everolimus for HR+ MBC with ESR1m based on evERA!!! @elmayermd @DFCI_BreastOnc
FDA approves giredestrant in combination with everolimus for ER-positive, HER2-neg... fda.gov/drugs/cancer-approva… clin.larvol.com/trial-detail… #LARVOL #CancerResearch #OncologyInsights #BreastCancer #EndocrineTherapy #FDAApproval @PTarantinoMD @SuyogCancer @dr_yakupergun @kazuki_nozawa































